These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11568514)

  • 1. Intravenous omeprazole in children: pharmacokinetics and effect on 24-hour intragastric pH.
    Faure C; Michaud L; Shaghaghi EK; Popon M; Turck D; Navarro J; Jacqz-Aigrain E
    J Pediatr Gastroenterol Nutr; 2001 Aug; 33(2):144-8. PubMed ID: 11568514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole.
    Hartmann M; Theiss U; Huber R; Lühmann R; Bliesath H; Wurst W; Lücker PW
    Aliment Pharmacol Ther; 1996 Jun; 10(3):359-66. PubMed ID: 8791964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of lansoprazole in children with gastroesophageal reflux disease.
    Gremse D; Winter H; Tolia V; Gunasekaran T; Pan WJ; Karol M; Chiu YL; Pilmer B; Book L
    J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 4():S319-26. PubMed ID: 12607792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis.
    Faure C; Michaud L; Shaghaghi EK; Popon M; Laurence M; Mougenot JF; Hankard R; Navarro J; Jacoz-Aigrain E
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1397-402. PubMed ID: 11552911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children.
    Tran A; Rey E; Pons G; Pariente-Khayat A; D'Athis P; Sallerin V; Dupont C
    Clin Pharmacol Ther; 2002 May; 71(5):359-67. PubMed ID: 12011821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: A randomized prospective study.
    Chwiesko A; Charkiewicz R; Niklinski J; Luczaj W; Skrzydlewska E; Milewski R; Baniukiewicz A; Wroblewski E; Rosolowski M; Dabrowski A
    J Dig Dis; 2016 Sep; 17(9):588-599. PubMed ID: 27518195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.
    Hatlebakk JG; Katz PO; Camacho-Lobato L; Castell DO
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1267-72. PubMed ID: 11012470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of CYP2C19 on the relationship between pharmacokinetics and intragastric pH of omeprazole administered by successive intravenous infusions in Chinese healthy volunteers.
    Wang Y; Zhang H; Meng L; Wang M; Yuan H; Ou N; Zhang H; Li Z; Shi R
    Eur J Clin Pharmacol; 2010 Jun; 66(6):563-9. PubMed ID: 20414645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status.
    Sugimoto M; Furuta T; Shirai N; Ikuma M; Hishida A; Ishizaki T
    Clin Pharmacol Ther; 2006 Nov; 80(5):539-48. PubMed ID: 17112810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z.
    Hunt RH; Armstrong D; Yaghoobi M; James C; Chen Y; Leonard J; Shin JM; Lee E; Tang-Liu D; Sachs G
    Aliment Pharmacol Ther; 2008 Jul; 28(2):187-99. PubMed ID: 18445141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.
    Andersson T; Röhss K; Bredberg E; Hassan-Alin M
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1563-9. PubMed ID: 11563995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of gastric acid with intravenous esomeprazole and omeprazole: results of 3 studies in healthy subjects.
    Röhss K; Wilder-Smith C; Kilhamn J; Fjellman M; Lind T
    Int J Clin Pharmacol Ther; 2007 Jun; 45(6):345-54. PubMed ID: 17595892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.
    Freston J; Chiu YL; Pan WJ; Lukasik N; Täubel J
    Am J Gastroenterol; 2001 Jul; 96(7):2058-65. PubMed ID: 11467632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
    Miner PB; Fort JG; Zhang Y
    Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of pantoprazole in clinically normal neonatal foals.
    Ryan CA; Sanchez LC; Giguère S; Vickroy T
    Equine Vet J; 2005 Jul; 37(4):336-41. PubMed ID: 16028623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients.
    Cederberg C; Thomson AB; Mahachai V; Westin JA; Kirdeikis P; Fisher D; Zuk L; Marriage B
    Gastroenterology; 1992 Sep; 103(3):913-8. PubMed ID: 1499942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model.
    Puchalski TA; Krzyzanski W; Blum RA; Jusko WJ
    J Clin Pharmacol; 2001 Mar; 41(3):251-8. PubMed ID: 11269565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.
    Sharma VK
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S18-21. PubMed ID: 10597120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.